People who use drugs

Testing PWID for HCV every 6 months could reduce HCV prevalence by up to 45%, incidence by 37%, and HCV-related deaths by 42% over 10 years. More

EUDA updates tool for tracking progress in eliminating viral hepatitis in people who inject drugs. More

EUDA and ECDC jointly release a European toolkit for the elimination of viral hepatitis in prisons. More

A review discussed the Catalonia’s current HCV programmes and explored intervention proposals needed to achieve WHO elimination targets. More

A perspective-paper argues that the adoption of harm reduction in Europe is lagging behind in important ways, leading to uneven and poor implementation of services. More